Work

EGFR and ALK Targeted Therapy Response in Non-Small Cell Lung Cancer Harboring Rare or Resistant Mutations: A Case Report and Molecular Insights

Year: 2026

Type: article

Study design: Case Report

Source: Current Cancer Drug Targets

DOI: 10.2174/0115680096458810260330094454

Authors: Anju Farsana Abdul Gafoor, Preena S Parvathy, C Gopi Mohan, Keechilat Pavithran

Institutions: Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154912910

FWCI:

Cites:

Cited by:

Related to: